[
    {
        "id": "osp-2336",
        "type": "article-journal",
        "title": "Chondroid Tenosynovial Giant Cell Tumor: A Rare Case Involving the Infratemporal Fossa",
        "author": [
            {
                "family": "Albakri",
                "given": "Abdullah"
            },
            {
                "family": "Bakathir",
                "given": "Abdulaziz"
            },
            {
                "family": "Al-Hashmi",
                "given": "Ahmed"
            },
            {
                "family": "Al-Saadi",
                "given": "Noor"
            },
            {
                "family": "Alshibani",
                "given": "Salma"
            },
            {
                "family": "Al-kalbani",
                "given": "Faisal"
            },
            {
                "family": "Al-Kindi",
                "given": "Hunaina"
            }
        ],
        "URL": "https://omanscience.com/en/articles/chondroid-tenosynovial-giant-cell-tumor-a-rare-case-involving-the-infratemporal-fossa",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2021
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2021.11",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "Tenosynovial giant cell tumor (TGCT) is a benign soft-tissue neoplasm that rarely occurs in the craniofacial region. We report a case of a 27-year-old male who presented to our unit in September 2017 with severe temporomandibular joint (TMJ) pain and progressive limitation opening his mouth. Based on clinical and imaging examinations, a well-defined soft tissue lesion was identified within the right infratemporal fossa, causing pressure on the TMJ and the surrounding structures. The lesion was surgically excised through trans-mandibular and endoscopic approaches. Histopathology diagnosis revealed a rare chondroid subset of TGCT. At 18 months follow-up, the patient showed resolution of the jaw pain, good functional and esthetic outcomes, and no evidence of recurrence."
    }
]